KITS USE HUMAN

Brand Owner (click to sort) Address Description
ALLOMUNE BioTransplant, Inc. Building 75 Third Avenue Charlestown MA 02129 kits for use in human to human organ transplants comprising one or more of the following components - myelosuppressive agents; antibodies to deplete organ transplant recipient's T cells and NK cells; cytokines; gene therapy vector, namely, a carrier molecule for expressing a gene; human bone marrow cells; and human organs;
AUTUMN DNA INOVO HOLDINGS INC. 16192 Coastal Hwy Lewes DE 19958 Kits for use in human genetic identity testing for scientific and research purposes comprising a saliva collection tube, caps for the saliva collection tube, and mailing packaging for use in DNA testing of humans; kits for use in DNA testing of humans for scientific and research purposes for development of personalized dietary supplements, namely, kits comprising a test tube, caps for the test tube, and laboratory swabs;Dietary supplements; Herbal supplements; Nutritional supplements; Vitamin supplements;AUTUMN DEOXYRIBONUCLEIC ACID;Providing personalized dietary and nutritional guidance and medical analysis based upon nutritional science, metabolic science, and results of personalized genetic testing; providing medical information to patients in the form of dietary and nutritional reports based on nutritional science, metabolic science, and results of personalized genetic testing;Kits for use in human genetic identity testing for medical purposes comprising a saliva collection tube, caps for the saliva collection tube, and mailing packaging for use in DNA testing of humans; medical test kits for use in DNA testing of humans for development of personalized dietary supplements, namely, medical test kits comprising a blood testing apparatus and a medical diagnostic apparatus for testing DNA and RNA samples;DNA;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The invention relates to kits and methods for assessing skin health for a human and the human's susceptibility to skin disorders. The methods involve assessing occurrence in the human's genome of one or more polymorphisms (e.g., single nucleotide polymorphisms) that occur in one or more genes associated disclosed herein and that are associated with a disorder in humans. Preferred assessment and scoring methods are disclosed, as are kits for performing the methods.